Letter: paying attention to the comorbidities or extraintestinal complications in patients with inflammatory bowel disease during the COVID-19 pandemic.

Yuan, Wen-Qiang; Li, Fei; Yang, Liu-Chan; Yang, Zai-Li; Cui, De-Jun

Yuan, Wen-Qiang; Li, Fei; Yang, Liu-Chan; Yang, Zai-Li; Cui, De-Jun.

Yuan WQ; Guizhou Medical University, Guiyang, China.
Li F; Department of Gastroenterology, National Institution of Drug Clinical Trial, Guizhou Provincial People's Hospital, Guiyang, China.
Yang LC; Department of Gastroenterology, National Institution of Drug Clinical Trial, Guizhou Provincial People's Hospital, Guiyang, China.
Yang ZL; Department of Gastroenterology, National Institution of Drug Clinical Trial, Guizhou Provincial People's Hospital, Guiyang, China.
Cui DJ; Guizhou Medical University, Guiyang, China.

Aliment Pharmacol Ther ; 55(11): 1464-1465, 2022 06.

Article in English | MEDLINE | ID: covidwho-1831964

Subject(s)

COVID-19; Colitis, Ulcerative; Inflammatory Bowel Diseases; Colitis, Ulcerative/complications; Humans; Inflammatory Bowel Diseases/complications; Inflammatory Bowel Diseases/epidemiology; Pandemics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Colitis, Ulcerative / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Language: English Journal: Aliment Pharmacol Ther Journal subject: Pharmacology / Gastroenterology / Drug Therapy Year: 2022 Document Type: Article Affiliation country: Apt.16915

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google